Sort
48,018 grants matching “immunotherapy”
Engineered extracellular vesicles derived from mesenchymal stem cells for the treatment of type 1 diabetes
$572,947Ryang Hwa Lee · Texas A&M University Health Science Ctr · R01 · FY2025 · DK
CANCER AND LEUKEMIA GROUP B
$572,909Brigham And Women'S Hospital · U10 · FY2000 · CA
A Prospective Cohort Study of Patients with Non-Small Cell Lung Cancer and Multiple Myeloma to Assess the Benefits and Harms Related to Cannabis Use During Treatment
$572,907Richard T Lee · Beckman Research Institute/City Of Hope · U01 · FY2024 · CA
Myeloid Specific Targeted Nanoimunotherapy for Organ Transplant Acceptance
$572,859Jordi Ochando · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · AI
Interleaved 1H/23Na imaging for invasive and proliferative phenotypes of brain tumors
$572,851Dewan Syed Fahmeed Hyder · Yale University · R01 · FY2023 · CA
Predicting Relapse at the Time of Diagnosis in Acute Lymphoblastic Leukemia
$572,741Kara Lynn Davis · Stanford University · R01 · FY2023 · CA
SAXS Facility
$572,736Yun Xing M Wang · Division Of Basic Sciences - Nci · ZIC · FY2025 · CA
The Role of HIF2 in Pancreatic Ductal Adenocarcinoma
$572,667Albert Koong · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
The Role of HIF2 in Pancreatic Ductal Adenocarcinoma
$572,667Cullen Mitsuo Taniguchi · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Developmental Funds
$572,612Eric R. Fearon · University Of Michigan At Ann Arbor · P30 · FY2023 · CA
OUTSTANDING INVESTIGATOR
$572,600University Of Minnesota Twin Cities · R35 · FY2000 · CA
TGX-1214 - Combination Strategy for the Treatment of Advanced Pancreatic Cancer
$572,502Gerardo Guillermo Mackenzie · University Of California At Davis · R01 · FY2025 · CA
Mechanoregulation of cytotoxic lymphocyte function
$572,485Morgan A Huse · Sloan-Kettering Inst Can Research · R01 · FY2024 · AI
Mechanoregulation of cytotoxic lymphocyte function
$572,485Morgan A Huse · Sloan-Kettering Inst Can Research · R01 · FY2025 · AI
Kinetic Assembly of Polymer-mRNA Nanoparticles Targets Circulating Monocytes to Enhance Cancer Immunotherapy
$572,485Hai-Quan Mao · Johns Hopkins University · R01 · FY2025 · CA
Mechanoregulation of cytotoxic lymphocyte function
$572,485Morgan A Huse · Sloan-Kettering Inst Can Research · R01 · FY2023 · AI
New Engineering Strategy for Harnessing Immune System against Head and Neck Cancer
$572,454James J. Moon · University Of Michigan At Ann Arbor · R01 · FY2024 · DE
Harnessing TNFa Signaling To Improve Therapeutic Response In Pancreatic Cancer
$572,447Kian H Lim · Washington University · R01 · FY2024 · CA
Disrupted Circadian Regulation of Cell Migration at CNS-Immune Interfaces in Aging and Alzheimer's Disease
$572,338Laura K Fonken · University Of Texas At Austin · R01 · FY2025 · AG
High Throughput Isolation of Antigen Specific T-cells for Cancer Therapy
$572,312Udai S Kammula · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Immunotherapy Strategies for Uveal Melanoma
$572,312Udai S Kammula · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Cell type-directed Tim-3 targeting in melanoma
$572,297Steven Russell Barthel · Brigham And Women'S Hospital · R01 · FY2023 · CA
A NON-HUMAN PRIMATE MODEL OF TUBERCULOSIS AND AIDS
$572,261University Of Pittsburgh At Pittsburgh · R01 · FY2003 · AI
Immunotherapeutic responses to neoantigens in head and neck cancer
$572,257Ravindra Uppaluri · Dana-Farber Cancer Inst · R01 · FY2022 · DE
Primary screening and hit follow up to identify the first selective inhibitors of PLC?1 and PLC?2
$572,254Zhong-Yin Zhang · Purdue University · R01 · FY2025 · CA